You have no items in your shopping cart.
Search results for: 'sars'
- Baricitinib (INCB28050, LY3009104) [orb146247]
[1187594-09-7]
371.417
C16H17N7O2S
1 ml x 10 mm (in DMSO), 1 g, 100 mg, 250 mg - Featured
Featured
Functional Studies, IA, WB
> 95%
137
HEK293 cells
100 μg - Featured
Featured
Functional Studies, IA, WB
> 95%
137
HEK293 cells
100 μg - Featured
Featured
Functional Studies, IA, WB
> 95%
137
HEK293 cells
100 μg - Featured
Featured
Functional Studies, IA, WB
> 95%
137
HEK293 cells
100 μg - Featured
Featured
≥95% (SDS-PAGE)
~60kDa (SDS-PAGE); ~115 kDa (Dimer) (SEC)
HEK293 cells
50 μg - Featured
Featured
≥95% (SDS-PAGE)
~60kDa (SDS-PAGE)
HEK293 cells
50 μg - Featured
Featured
≥95% (SDS-PAGE)
~60kDa (SDS-PAGE)
HEK293 cells
50 μg - Featured
Featured
≥95% (SDS-PAGE)
~60kDa (SDS-PAGE)
HEK293 cells
50 μg 410.37 kDa; Protein contains amino acids 14-1211 and following mutations: T19R, G142D, E156G, del_F157-R158 L452R, T478K, D614G, P681R. Plus two extra amino acids (AS) in N-terminus, trimerization domain and His-6 tag at C-terminus, GS linker between protein and trimerization domain and GSG linker between trimerization domain and His-tag. Furin cleavage (RRAR) site between Spike S1 and S2 is mutated (GSAS).
CHO-based cell line (expressed by QMCF Technology)
50 μg, 10 μg, 100 μg









